Neutrophil to lymphocyte ratio in oropharyngeal squamous cell carcinoma: A systematic review and meta-analysis

JP Rodrigo, M Sánchez-Canteli, A Triantafyllou… - Cancers, 2023 - mdpi.com
Simple Summary Neutrophil-to-lymphocyte ratio (NLR) in peripheral blood samples has
been associated with prognosis in several cancers, including head and neck cancer, but in …

Fluid biomarkers in HPV and non-HPV related oropharyngeal carcinomas: from diagnosis and monitoring to prognostication—a systematic Review

SC Lee, KKC Leung, ACY Chung, ESY Wong… - International Journal of …, 2022 - mdpi.com
Biomarkers are crucial in oncology, from detection and monitoring to guiding management
and predicting treatment outcomes. Histological assessment of tissue biopsies is currently …

Evaluation of optimal threshold of neutrophil-lymphocyte ratio and its association with survival outcomes among patients with head and neck cancer

SJ Ma, H Yu, M Khan, J Gill, S Santhosh… - JAMA Network …, 2022 - jamanetwork.com
Importance Given the role of inflammation in cancer progression, neutrophil-lymphocyte
ratio (NLR) from peripheral blood has been suggested as a readout of systemic …

Novel Strategies to Effectively De-escalate Curative-Intent Therapy for Patients With HPV-Associated Oropharyngeal Cancer: Current and Future Directions.

KAR Price, AC Nichols, CJ Shen… - American Society of …, 2020 - europepmc.org
The treatment of patients with HPV-associated oropharyngeal cancer (HPV-OPC) is rapidly
evolving and challenging the standard of care of definitive radiotherapy with concurrent …

Pretreatment lymphocyte count predicts benefit from concurrent chemotherapy with radiotherapy in oropharyngeal cancer

JM Price, HB Mistry, G Betts, EJ Cheadle… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE There is a need to refine the selection of patients with oropharyngeal squamous
cell carcinoma (OPSCC) for treatment de-escalation. We investigated whether pretreatment …

Significance of neutrophil to lymphocyte ratio as a predictor of outcome in head and neck cancer treated with definitive chemoradiation

J Kaźmierska, T Bajon, T Winiecki… - Reports of Practical …, 2023 - journals.viamedica.pl
Background: The role o fh ost immune system in carcinogenesis and response to treatment
is increasingly studied, including predictive potential of circulating neutrophils and …

Comparison of selected immune and hematological parameters and their impact on survival in patients with HPV-related and HPV-unrelated oropharyngeal Cancer

A Brewczyński, B Jabłońska, AM Mazurek… - Cancers, 2021 - mdpi.com
Simple Summary This is a research article on oropharyngeal cancer (OPC). The aim of the
study was to assess and compare basic immune parameters and ratios in patients with …

Defining the optimal threshold and prognostic utility of pre-treatment hemoglobin level as a biomarker for survival outcomes in head and neck cancer patients …

SJ Ma, H Yu, M Khan, B Yu, S Santhosh, U Chatterjee… - Oral oncology, 2022 - Elsevier
Objectives We sought to define the optimal threshold for anemia in North American head
and neck cancer patients and evaluate its role as a prognostic biomarker. Materials and …

Prognostic significance of neutrophil‐to‐lymphocyte ratio in HPV status era for oropharyngeal cancer

G Fanetti, D Alterio, G Marvaso, S Gandini… - Oral …, 2020 - Wiley Online Library
Aim To evaluate the role of baseline neutrophil‐to‐lymphocyte ratio (NLR) as prognostic
marker in squamous cell carcinoma of the oropharynx (OPC) treated with definitive …

Pretreatment hemoglobin level as a prognostic factor in patients with locally advanced head and neck squamous cell carcinoma

C Melo-Alvim, P Miguel-Semedo… - Reports of Practical …, 2020 - journals.viamedica.pl
Aim Evaluate pretreatment hemoglobin values as a prognostic factor in patients with locally
advanced head and neck squamous cell carcinoma treated with concurrent …